89% protection from Omicron with Pfizer tablets

Pfizer said on Tuesday that it expects its Covid-19 tablet, which is in the launch phase, to be protected from omega. A study of 2250 people showed positive results in the case of the pill. The pill protects 89% of those infected with Omicron rather than being hospitalised and dying. Observers predict that the US Food and Drug Administration (FDA) will make a key announcement soon. A study by South African researchers found that two doses of the Pfizer / Biotech vaccine provided only 33 percent protection against the omega-3 variant and 70 percent protection against hospitalisation.

The study has been conducted in South Africa and Botswana since the beginning of the Omicron variant. Researchers at the University of Cambridge in the UK, in collaboration with DIOSynVax, have come up with an innovative way to provide an easy vaccine for those who are worried about vaccination with a needle. In this method the vaccine powder is injected into the skin by air pressure in a small hand machine. Researchers at the University of Oxford have recently revealed that vaccination has increased in countries where the vaccine average is lower than 20 days before and 40 days after Covid-19 -negative certification is mandatory for international travel.